ArticleEuropean journal of nuclear medicine and molecular imaging2023

[18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab.

Romain-David Seban et al.PubMed ↗Publisher ↗

No numbers read from the abstract.